CORT Q3 2021 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$96M+11.4% YoY

Gross Profit

$95M98.7% margin

Operating Income

$36M37.7% margin

Net Income

$30M31.7% margin

EPS (Diluted)

$0.24

QoQ Revenue Growth

+5.0%

Cash Flow

Operating Cash Flow

$49M

Free Cash Flow

$49M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$585M

Total Liabilities

$45M

Stockholders' Equity

$540M

Cash & Equivalents

$95M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$96M	$86M	+11.4%
Gross Profit	$95M	$85M	+11.4%
Operating Income	$36M	$25M	+46.6%
Net Income	$30M	$22M	+40.9%